FDA approves Lynparza’s use in a wider group of women.
Byteflies’ Sensor Dot will help monitor brain, heart and respiration activity.
While many of the hopes and disappointments for AZ’s business are around oncology, it still needs its cardiovascular and diabetes portfolio to perform.
How big data and patient centricity are changing the Medical Affairs function.
Status of immunotherapies in non-small cell lung cancer (NSCLC).
mHealth, AI and IoT have all been hyped, but what is their potential long-term value to healthcare?
How neurostimulation and IoT are set to revolutionise healthcare with personalised monitoring and precision therapies.
06/09/2017August 2, 2017
20/06/2017June 1, 2017
‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.